Sunday, July 12, 2020

Racial Disparities Persist Across Wealth, Health, Employment, Education And Beyond

Systemic racism, or institutional racism, or structural racism, has led to persistent discrimination and disparities in wealth, health, education, politics, and beyond in the United States. Recently, we have seen racial disparities in the ongoing coronavirus pandemic, affecting more African Americans than white Americans.

Coronavirus: NIAID Director Says “Anti-Science Bias” In the US Could Be Problematic

Dr. Anthony Fauci, the head of NIAID, said the “anti-science bias” in the United States is problematic. He said many people just do not believe experts who are talking about the science behind the ongoing coronavirus pandemic. He also talked about the COVID-19 vaccine development process.

FDA Approves HIV Drug Tivicay for Pediatric Patients

The FDA approved Tivicay and Tivicay PD for the treatment of HIV-1 infection in pediatric patients. Tivicay contains dolutegravir, an antiretroviral medication that treats and prevents HIV/AIDS. The FDA granted the approval of Tivicay and Tivicay PD to Viiv Healthcare.

Fentanyl Linked To Most Fatal Overdoses in Maryland, Finds Study

A new study has found that fentanyl has topped the list of drug overdoses in two Baltimore hospital emergency departments. This finding has led researchers to consider fentanyl a drug associated with fatal overdoses in Maryland. Fentanyl testing was not typically performed because it was rarely a cause of overdose.

Doctors Sue FDA for Limiting Hydroxychloroquine Access to Treat COVID-19 Patients

A group of physicians has filed a lawsuit against the Food and Drug Administration (FDA) for limiting access to hydroxychloroquine for patients with COVID-19. The FDA, last week, raised concerns over the side effects of hydroxychloroquine on the cardiovascular system, deeming it unsafe.

Clinical Trial Shows Netakimab Effective at Treating Plaque Psoriasis

Netakimab, a humanized monoclonal antibody that targets interleukin-17A, has been found effective at treating moderate to severe skin manifestations caused by psoriasis. In a clinical trial, the drug has significantly improved the skin manifestations of psoriasis.

Epidemiologist Says Coronavirus Is Likely To Be a Seasonal Disease

A team of researchers from the University of Sydney has explained that COVID-19 could be a seasonal disease and the number of cases may peak in the winter season. The team studied the link between lower humidity and the number of COVID-19 cases. They said a 1% decrease in humidity would increase the cases by 6%.